ACRS
NASDAQ · Pharmaceuticals
Aclaris Therapeutics Inc
$5.50
+0.10 (+1.85%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+57.59%
1Y
+52.35%
YTD
+52.35%
Open$5.41
Previous Close$5.40
Day High$5.54
Day Low$5.36
52W High$6.60
52W Low$1.74
Volume—
Avg Volume2.99M
Market Cap794.87M
P/E Ratio—
EPS$-0.59
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$4.51
Above
RSI (14)
55.5
Neutral
Analyst Ratings
Strong Buy
18 analysts
Price Target
+223.5% upside
Current
$5.50
$5.50
Target
$17.79
$17.79
$13.99
$17.79 avg
$22.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.55M | 14.90M | 98.24M |
| Net Income | -79,143,751 | -111,174,302 | 16.97M |
| Profit Margin | -829.6% | -788.1% | 17.3% |
| EBITDA | -92,546,044 | -137,222,946 | 25.23M |
| Free Cash Flow | — | — | 16.84M |
| Rev Growth | -35.9% | -35.9% | +7.1% |
| Debt/Equity | — | — | 1.07 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,150.99 | -1.64% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.17 | -0.01% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $148.08 | -1.88% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.18 | +0.90% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $61.15 | -1.77% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.61 | -1.72% | 11.5 | 30.15B |